BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35780401)

  • 1. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
    Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
    Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
    Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
    Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade endometrial stromal sarcoma versus undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.
    Ayhan A; Tunc M; Boran N; Khatib G; Gokcu M; Simsek T; Ozen OI; Toptas T; Yalcin I; Meydanli MM
    Arch Gynecol Obstet; 2021 Aug; 304(2):475-483. PubMed ID: 33392719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
    Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
    BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
    Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
    Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.
    Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL
    Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
    Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
    Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
    Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
    Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT study.
    Macuks R; Yildirim Y; Mancari R; Achimas-Cadariu P; Madhuri TK; Ortega E; Mallmann M; Zivanovic O; Zapardiel I;
    Arch Gynecol Obstet; 2023 Sep; 308(3):981-988. PubMed ID: 37193821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
    Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
    Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of lymphadenectomy in uterine leiomyosarcomas and endometrial stromal sarcomas: Systematic review and meta-analysis.
    Li Y; Gong Q; Peng J; Liu Y; Jiang Y; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2022 Dec; 279():94-101. PubMed ID: 36308940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.